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In Vitro Characterization of HIV Type 1 Biological Clones
from Asymptomatic and Symptomatic Pédiatrie Patients
SERENE E. FORTE, JOHN L. SULLIVAN, and MOHAN SOMASUNDARAN
ABSTRACT
To investigate the mechanisms of HIV-1 cytopathogenicity, functional biological HIV-1 clones were isolated
from two infected children with high viral loads in vivo. Clone HC4 was isolated from a symptomatic child
and clone GC6 8-4 was isolated from an asymptomatic child. These clones were characterized for their abil-
ity to induce syncytia, and to replicate and induce single-cell death in peripheral blood-derived normal CD4
T cell cultures containing anti-CD4 antibody. Despite similar viral loads as determined by p24 antigen pro-
duction or viral RNA expression, GC6 8-4 was noncytopathogenic and HC4 was cytopathogenic. Since we had
demonstrated that mitochondrial dysfunction correlated with HIV-1-induced cell death, we determined
whether the cytopathogenic HC4 clone decreased mitochondrial viability using a mitochondrial-specific dye,
rhodamine-123. Following infection, mitochondrial viability decreased in cells infected with HC4 by day 4 and
continued to decline through day 7 when compared to uninfected cells. By day 7 postinfection, greater than
80% of the cells in culture were dead. Similar analyses on CD4 T cells infected with the noncytopathogenic
GC6 8-4 demonstrated that mitochondria remained functionally viable and >90% of the cells excluded try-
pan blue. These studies describe a cell culture system to study single-cell death in the absence of syncytia and
secondary infection. Results with two patient-derived HIV-1 biological clones suggest that loss of mitochon-
drial viability may play a role in HIV-1-induced cytopathogenicity.
INTRODUCTION
Human immunodeficiency virus type 1-induced cytopath-ogenicity leads to a quantitative depletion of and abnor-
mal function of CD4 T cells in vivo and is a major factor con-
tributing to the immunosuppression associated with HIV-1
infection.1-2 The mechanism of in vivo HIV-1-induced cyto-
pathic effects that contribute to the dramatic loss of CD4 T cells
remains unknown. In addition to high viral load usurping the
host cell synthetic machinery,3 proposed mechanisms of cy-
topathogenicity include syncytium formation,4 intracellular
HTV-1 gpl60/120-CD4 complexing,5 accumulation of uninte-
grated viral DNA,6 viral-induced apoptosis,7 and viral-induced
mitochondrial toxicity.8 These studies suggest a cause-and-ef-
fect relationship between the viral life cycle and cytopathic ef-
fects.
Earlier reports have suggested an association between high
viral burden and HIV-1-induced CD4 T cell attrition in vivo.910
Reports have correlated rapid decline of CD4 T cells in vivo
with high levels of peripheral viremia.11-12 However, we have
observed rare individuals with high viral load who maintain
normal numbers of CD4 T cells for prolonged periods of time.
This suggested to us that the two processes of viral replication
and viral induced cytopathogenicity can be segregated and that
high levels of viral replication can be maintained without caus-
ing cell death. We hypothesize that the low cytopathogenic po-
tential of the virus may be responsible for certain infected in-
dividuals with high viral burdens remaining well with an intact
immune system.
In the present study, we describe the biological characteri-
zation of HIV-1 isolates from two seropositive, pédiatrie indi-
viduals. Functional biological clones of the primary isolates
were obtained by limiting dilution culture. The syncytium-in-
ducing (SI) and non-syncytium-inducing (NSI) phenotype in
MT-2 cells, and the replication characteristics and cytopatho-
genic potential in normal peripheral blood CD4 T cells, were
analyzed. One biological clone isolated from a symptomatic
child with AIDS induced cell death in the absence of syncytium
formation. In contrast, another HIV-1 clone isolated from an
asymptomatic individual was noncytopathogenic. We have pre-
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viously reported that decreases in mitochondrial viability play
a role in T cell death induced by cytopathogenic laboratory iso-
lates of HIV-1.8 Data supporting a possible role for mitochon-
dria in cell death induced by patient biological clones in vitro
are presented in this article.
MATERIALS AND METHODS
Patients
Patient A was clinically asymptomatic and was Nl accord-
ing to the Centers for Disease Control (CDC, Atlanta, GA) clas-
sification of disease stage. At the time of viral isolation, patient
A was 47 months old, with normal CD4 counts of 2312/mm3.
Unexpectedly, peripheral viremia in this child was very high as
determined by serum HIV-1 p24 antigen levels (1773 pg/ml)
and plasma viral RNA copies (280,000/ml). Since the original
viral isolate was obtained patient A has maintained normal CD4
T cell numbers, and p24 antigen levels along with plasma vi-
ral RNA levels have remained elevated. Patient D had AIDS at
the time of viral isolation and was B3 according to the CDC
classification of disease stage. The child was 36 months old
with very low CD4 T cell counts (64/mm3).
Isolation and titration of viruses
HIV-1 was isolated from the infected children described
above by coculture with phytohemagglutinin (PHA)-stimulated
normal seronegative donor peripheral blood mononuclear cells
(PBMCs) according to the AIDS Clinical Trial Group (ACTG)
VRL protocol.13 Viral isolates from patients A and D were
titered using standard methods on PHA-stimulated normal
seronegative donor PBMCs.14
Biological cloning
Biological clones of HIV-1 were obtained from the viral iso-
lates of patients A and D according to a modified procedure de-
scribed earlier by Connor et al.15 Briefly, PHA-stimulated
seronegative donor PBMCs were infected with primary isolates
obtained from patient A at 47 months of age and from patient
D at 36 months of age. These cell cultures were monitored for
cell-free HIV-1 p24 antigen on days 4 and 7 postinfection.
When p24 levels exceeded 30 pg/ml, the infected cells were di-
luted in a 4-fold series and seeded in 96-well plates in repli-
cates of 10 containing from 1000 to 0.24 cells/well. Infected
cells were cocultured with 1 X 106 PHA-stimulated seronega-
tive donor PBMCs per well. Cultures were monitored for cell-
free HIV-1 p24 antigen on days 7 and 11 postcoculture. A cul-
ture was considered positive if the p24 values was >30 pg/ml.
HIV-1 from wells seeded with less than one infected cell per
well was propagated in a single short-term coculture (5-7 days)
with PHA-stimulated seronegative donor PBMCs and was
titered on seronegative PBMCs to determine the 50% tissue cul-
ture infectious dose (TCID50).
Determination of clonality
Clonality of the putative biological clones was assessed by
analyzing the nucleotide sequences within the V3 domain of
the HIV-1 env gene obtained from cell lysates of PBMCs in-
fected with each of the putative biological clones. Amplification
by polymerase chain reaction (PCR) and direct sequencing of
the V3 domain were carried out by previously described meth-
ods.15 Briefly, sequences containing the V3 region of HIV-1
env were amplified by PCR, using the following primers: V30+(5' TACAATGTACACATGGAATT, position 6535-6554 of
HXB2) and V30" (5' ATTACAGTAGAAAAATTCCCC, po-
sition 6959-6939 of HXB2).15"18 The PCR products from these
reactions were subjected to a second round of asymmetric PCR,
using a single internal primer: either PCR-1(+) (5' GCTAAA-
ACCATAATAGTACAGCTG, position 6642-6665) or PCR-
2(-) (5' CAATTTCTGGGTCCCCTCCTGAGG, position
6915-6892). 15~18 The resulting single-stranded products were
then directly sequenced, using the Sequenase version 2.0 kit(United States Biochemicals, Cleveland, OH). Multiple bio-
logical clones were isolated from each of the primary isolates
of patient A and patient D. Further characterization of HIV-1
cytopathogenicity and the role of mitochondria were determined
using a single clone from patient A (GC6 8-4) and from patient
D (HC4).
In vitro characterization of syncytium-inducing
viral phenotype
The syncytium-inducing (SI) and non-syncytium-inducing(NSI) phenotype of HIV-1 biological clones were determined
in MT-2 cells, using the standardized protocol formulated by
the ACTG Virology Committee.19,20 Titered stocks of HIV-1
clones (50 ¿ri) were used to infect quadruplicate microcultures
of MT-2 cells (5 X 104) in wells of 96-well tissue culture plates
containing 200-pl final volume. Positive controls were set up
using titered stocks of HIV-1 NL4-3 (TCID5O/50 pi = 32,750).
Negative controls were either RPMI 1640 medium containing
10% fetal calf serum (FCS), or 8E5 cell culture supernatant con-
taining a po/-defective, noninfectious NL4-3 HIV-1 strain.21
Plates were incubated at 37°C (5% C02). Every third day the
wells were examined for syncytia, the cell suspension in each
well mixed, and 130 pi of the cell suspension discarded and re-
placed with 150 pi of fresh medium. On day 14 the NSI/SI phe-
notype of each biological HIV-1 clone was recorded and the
assay was terminated. If three to five "balloons" or giant cells
were detected per well under high power field, the cell culture
was scored as positive for syncytia and the phenotype of the
biological viral clone was recorded as SI. An HIV-1 clone that
did not induce syncytia in MT-2 cells was phenotyped as NSI.
Infection of PBMCs with biological clones ofpatient
HIV-1 isolates
Normal PBMCs from HIV-1-seronegative donors were PHA
stimulated for 3 days and infected with HIV-1 biological clones,
GC6 8-4 and HC4, according to previously described meth-
ods.3,22 HIV-1-infected and uninfected PBMCs were cultured at
1 X 106 cells/ml in RPMI 1640 supplemented with 10% fetal calf
serum (FCS) and 10 units of recombinant human interleukin 2
(Boehringer-Mannheim, Indianapolis, IN) per milliliter.
Enrichment of CD4 T cells
PBMCs were isolated using the Ficoll gradient technique and
CD4 T cells were negatively enriched using anti-CD8 antibody-
CYTOPATHOGENICITY OF HIV-1 BIOLOGICAL CLONES 1587
coated magnetic beads (Dynal, Inc., Lake Success, NY) ac-
cording to the manufacturer's methodology. Briefly, the beads(10 beads/cell) were washed three times with phosphate-
buffered saline (PBS) containing 1% FCS (PBS-1% FCS).
During each wash, the beads were collected using a magnetic
separator. After the final wash, the beads were resuspended in
100 pi of ice-cold PBS-1% FCS. PBMCs (108 cells) were
washed once with PBS-1% FCS, resuspended in 1 ml of ice-
cold PBS-1% FCS and added to the bead suspension. The mix-
ture was incubated on ice for 20 min with gentle agitation. The
tube was placed upright in a magnetic separator for 5 min and
the supernatant was collected. The beads were washed twice
with PBS-1% FCS and the supernatants were saved. The su-
pernatants containing CD4 T cells were spun and the cell pel-
let was resuspended in RPMI 1640 containing 10% FCS and
interleukin 2 (10 units/ml).
Infection of CD4 T cells with biological HIV-1 clones
CD4 T cells were PHA stimulated overnight and infected
with HIV-1 biological clones according to previously de-
scribed methods.3-22 To determine whether the interaction of
viral gpl20 envelope protein and CD4 antigen was responsi-
ble for intracellular events leading to cell death, CD4 T cells
were also infected with cell-free supernatant obtained from
cultures of chronic, replication-incompetent HIV-1 producers,
8E5 cells. These mock-infected CD4 T cells served as con-
trols for infection experiments. HIV-1-infected and uninfected
CD4 T cells were cultured at 1 X 106 cells/ml in RPMI 1640
supplemented with 10% FCS and recombinant human inter-
leukin 2 (10 units/ml; Boehringer-Mannheim) in the continu-
ous presence of azide-free anti-CD4 antibody at 100 ng/ml(Biosource International, Camarillo, CA). The anti-CD4 anti-
body was targeted to the epitope on CD4 antigen that binds
to HIV-1 gpl20 envelope. This antibody prevented syncytium
formation and blocked secondary infections and, therefore,
modified the culture conditions to study single cell death in-
duced by HIV-1.
Assay for HIV-1-induced cytopathogenic effects
HIV-1-induced cytopathogenic effects of GC68-4 and HC-4
viral clones were determined by evaluating cell viability using
the method of trypan blue dye exclusion. Biological clones were
determined to be noncytopathogenic (NCP) or cytopathogenic(CP) on the basis of the viability of infected cells.
Determination of CD4 + and CD8 + T cell populations
in infected cultures
Cells (-500,000) from infected and uninfected T cell cul-
tures were washed with cold PBS-0.1% azide and then incu-
bated for 30 min on ice with a mixture of fluorescein labeled
anti-CD4 monoclonal antibody and phycoerythrin-labeled anti-
CD8 monoclonal antibody (Becton Dickinson, San Jose, CA).
The cells were washed with PBS-0.1 % azide and then fixed for
10 min at room temperature with 0.2% paraformaldehyde. The
cells were washed with PBS-0.1% azide and then resuspended
in PBS and analyzed on a FACScan flow cytometer (Becton
Dickinson). Phycoerythrin- and fluorescein-labeled mouse
gammaglobulins were used as negative stains for controls.
Determination ofproviral copies: Polymerase chain
reaction to detect HIV-1 DNA
Polymerase chain reaction was performed on lysates of se-
rially diluted CD4 T cells infected with GC6 8-4 or HC4 HIV-
1 biological clones, using a Roche Amplicor HIV-1 test kit ac-
cording to a method described by Saiki et al.23 and modified
by the manufacturer. A region within the HIV-1 gag gene was
amplified using biotinylated SK431/SK462 primer pairs in an
automated GeneAmp PCR system 9600 thermocycler (Perkin-
Elmer Cetus, Foster City, CA). The cycling parameters were as
follows: 5 cycles of denaturation at 95°C for 10 sec, annealing
at 55°C for 10 sec, and extension at 72°C for 10 sec; followed
by 30 cycles of denaturation at 90°C for 10 sec, annealing at
60°C for 10 sec, and extension at 72°C for 10 sec; followed by
a final extension step at 72°C for 5 min. The amplicons were
captured onto wells coated with the probe and detected by an
enzyme-linked immunosorbent assay (ELISA) using avidin-
conjugated horseradish peroxidase as a secondary marker.
Determination of viral replication: ELISA to detect
HIV-1 p24&*s protein
To follow HIV-1 replication in infected PBMCs or CD4 T
cell cultures, cell-free culture supernatants were assayed for
HIV-1 P24*1*« protein using an antigen capture ELISA (Coulter
Immunology, Hialeah, FL) according to the method described
by the manufacturer.
Determination of viral replication: Fluorescent in situ
hybridization to detect HIV-1 RNA
A sample of infected cells was washed with PBS, air dried
on microscope slides, and fixed in 4% paraformaldehyde for 10
min at room temperature. The slides were rinsed in PBS and
stored in 70% ethanol. At the time of assay, cells were rehy-
drated and HIV-1 RNA was detected by in situ hybridization
using a cocktail of 50 digoxigenin-labeled synthetic oligonu-
cleotide probes (35-mers) targeted to the entire HIV-1
genome.8-24 Briefly, 100 ng of oligonucleotide probes in 30%
formamide-2x SSC-5% dextran sulfate-2 mM vanadyl sulfate
complex-1% bovine serum albumin was hybridized overnight
at 37°C to HIV-1 RNA in infected cells. After a series of washes
at 37°C (2X SSC-30% formamide; IX SSC-30% formamide;
1X SSC) the cells were washed with PBS-0.1% Triton X-100.
FITC-labeled anti-digoxigenin antibody (0.5 pglml) was used
as the marker to detect the hybridized oligonucleotide probes.
The percentage of HIV-1 RNA-positive cells was determined
in cultures of cells infected with either GC68-4 or HC4 HIV-1
biological clones.
Determination of mitochondrial viability in cells
acutely infected with HIV-1 biological clones
Mitochondrial viability of CD4 T cells from infected cul-
tures was monitored using a rhodamine-123 dye assay.25
Briefly, uninfected and infected cells were washed, resuspended
in PBS containing 0.1 pM rhodamine-123 dye, and incubated
in a 37°C incubator with 5% CO2 for 15 min. The cells were
washed and resuspended in PBS and then analyzed by FACScan
flow cytometer (Becton Dickinson). The histograms of unin-
fected, mock-infected, and HIV-1 clone-infected CD4 T cells
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were analyzed using Kolmogorov-Smirnov statistics and over-
lay plots and summation curves were obtained.26 The summa-
tion curves of the histograms for infected and uninfected cells
represented the probability distribution of the individual his-
tograms. The D/s(n) value for the summation curves indicated
the degree of similarity between the two histograms. The fur-
ther the D/s(n) value is from zero, the more dissimilar the his-
tograms were, indicating that the number of viable mitochon-
dria was different between the two cell cultures.
RESULTS
Patients and HIV-1 isolates
The absolute CD4 cell counts of HIV-1-seropositive pédi-
atrie patients A and D are 2312 and 64 counts/mm3, respec-
tively. The biological characterization of HIV-1 isolates from
these two patients has been described earlier.27 The primary
HIV-1 isolate A (obtained from patient A at 47 months of age)
and the HIV-1 isolate D (obtained from patient D at 36 months
of age) were isolated just prior to initiation of therapy and have
been used in studies reported here.
Clonality of patient HIV-1 biological clones
Multiple biological clones were obtained from HIV-1 iso-
lates A and D. A single strand of DNA, 300 bases long within
the V3 region of the env gene, was amplified and sequenced by
PCR from cell lysates of PBMCs infected with the biological
clones. Nucleotide sequence analysis of the products from four
separate PCR and sequencing reactions for each putative clone
indicated less than 2% divergence within the V3 region15 and,
thus, confirmed the clonality of each HIV-1 isolate.
1 ). HIV-1 clones HC4 and GC6 8-4 had the highest titers among
the viral clones and were further characterized for their cyto-
pathic effects.
Primary infection of PBMCs with HIV-1 isolates A
and D
PHA-stimulated donor PBMCs were infected with patient
isolate A or D. The viability of PBMCs infected with HIV-1
isolate A did not decrease and remained comparable to the vi-
ability of uninfected cells over a period of 21 days (Fig. la). In
contrast, there was a steady decline in the percentage of viable
cells in cultures of PBMCs infected with isolate D. There was
a precipitous drop in viability after the 12th day postinfection
(Fig. lb). By 21 days, there was >80% of dead cells in isolate
D-infected culture when compared to <20% in uninfected cul-
ture. Viral production was determined by measuring the levels
of p24 antigen in cell-free supernatant. By day 7 postinfection,
the p24 antigen levels were similar (—40 ng/ml) in cultures of
PBMCs infected with either isolate A or isolate D.
Uninfected
Isolate A
12 15 19 21
Non-syncytium-inducing/syncytium-inducing phenotype
of biological clones
All the biological clones from isolate D were SI and all the
biological clones from isolate A were NSI in MT-2 cells (Table
Days Post-Infection
Table 1. Phenotype of Functional Biological
Clones Isolated from HIV-1 Isolates A
(NONCYTOPATHOGENIC) AND D (CyTOPATHOGENIC)
Clone MT-2 phenotype*
Viral isolate A (NCP)
GC6 8-1
GC6 8-4c
GC6 9-4
Viral isolate D (CP)
HC4C
HC5
HC6
HC7
HC8
HC9
HC10
NSI
NSI
NSI
SI
SI
SI
SI
SI
SI
SI
Viral titer0
103,158
259,678
4,061
64,958
16,242
16,242
6,446
10,232
64,958
6,446
aSI, Syncytium inducing; NSI, nonsyncytium inducing.
bTCID50/ml.
cBiological clones selected for further characterization.
60
40
20
0
-l-1-1-T"
0 3 5 7
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9 12 15 19 21
Uninfected
Isolate D
Days Post-Infection
FIG. 1. Viability of peripheral blood mononuclear cells(PBMCs) infected with patient HIV-1 isolates. Mitogen-stim-
ulated PBMCs were infected with titered patient HIV-1 stocks
as described in Materials and Methods. Cell death was deter-
mined using the trypan blue dye exclusion assay and percent
viable cells was calculated. Data from five individual experi-
ments are presented along with standard deviations, (a) PBMCs
infected with noncytopathogenic, HIV-1 isolate A; (b) PBMCs
infected with cytopathogenic, HIV-1 isolate D.
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Cytopathogenicity of HIV-1 biological clones in
PBMCs and CD4 T cells
PBMCs were infected with the biological HIV-1 clones HC4
and GC6 8-4. Both viruses replicated to high titers in PBMCs.
By day 8 postinfection, p24 antigen levels in cultures infected
with GC6 8-4 were >230 ng/ml, and in cultures infected with
HC4 the p24 antigen levels were >130 ng/ml. However, the
two cloned viruses had a much different effect on cell viabil-
ity. Ten days postinfection with HC4 clone, cell viability had
fallen below 50% compared to the —80% viability of uninfected
PBMCs. In contrast, 10 days postinfection with GC6 8-4 clone,
the cell viability was 75-80%.
The PBMC cultures described above were a mixture of CD4
and CD8 T cells. Since CD8+ T cells are not susceptible to HTV-
1 infection and HTV-1-induced cell death, the determination of
cell viability in HTV-1 -infected PBMC cultures does not truely
represent the effects of the virus. Moreover, the clone HC4 has
an SI phenotype and can potentially induce syncytia in CD4 T
cells. To eliminate the possible contributions of these factors to
cell death in infected cultures and to determine the mechanism
of single cell lysis by HTV-1, we modified our in vitro culture
conditions. Phytohemagglutinin-stimulated, CD4 T cells were
used to determine the cytopathogenic potential of HC4 and GC6
8-4 HIV-1 clones. After the initial exposure to the virus, the cells
were washed and then cultured in the presence of anti-CD4 an-
tibody to inhibit syncytium formation. Comparable levels of
HTV-1 expression in CD4 T cells were observed with both viruses
as shown in Table 2. In situ hybridization analysis to detect vi-
ral RNA expression revealed that by day 7 postinfection, the per-
centage of HIV RNA-positive cells in HC4-infected cultures was
29 and 25% in GC6 8-4-infected cultures (Table 2). Quantitative
PCR analyses using HTV-1 gag-specific primer pairs suggested
that the proviral copy numbers were similar in CD4 T cell cul-
tures infected with either GC6 8-4 or HC4 HTV-1 clones (1
copy/10 cells). By day 7 postinfection, p24 antigen levels in cul-
Table 2. HIV-1 RNA Expression and Mitochondrial
Viability of CD4+ T Cells Infected with
Noncytopathogenic or Cytopathogenic
HIV-1 Biological Clones
Days Percent Mitochondrial
postinfection expressing HPV-1 RNA3 viability"
Clone HC4
3 NCC ND
5 25.4 6.52
7 29.4 13.09
10 ND ND
Clone GC6 8-4
3 ND ND
5 15.9 2.02
7 25.3 2.28
10 ND 5.12
"Percent positive cells by in situ hybridization.hD/s(n) value from summation curves.
CND, Not done.
tures infected with GC6 8-4 were 363 ng/ml, and in cultures in-
fected with HC4 the p24 antigen levels were 342 ng/ml (Fig. 2c).
Despite the similar viral load observed in the two infected cul-
tures, there was a dramatically different effect on single cell ly-
sis. Cell viability in cultures infected with the HTV-1 clone, HC4,
showed a dramatic drop between day 5 (80%) and day 7 (45%)
postinfection (Fig. 2a). In contrast, viability of cells in cultures
infected with the GC6 8-4 clone was >80% and remained as vi-
able as the uninfected culture or the mock-infected culture dur-
ing the period of the experiment (Fig. 2a). Loss of viability in
uninfected CD4 T cell cultures by day 10 was probably due to
the lack of additional PHA restimulation that is necessary for
CD4 T cells to continue growth in the absence of CD8+ T cell-
derived cytokines. The noncytopathic effect of GC6 8-4 and the
cytopathic effect of HC4 were also evident by evaluating cell
growth in cultures. Between days 5 and 7 postinfection, the to-
tal number of cells in HC4-infected cultures declined from 40
million to 5 million cells and at day 10 there were less than 2
million cells remaining (Fig. 2b). In contrast, the total number of
cells in GC6 8-4-infected cultures, mock-infected cultures, or un-
infected cultures steadily increased from 50 million cells on day
5 to >150 million cells by day 10 postinfection (Fig. 2b).
The percentage of CD4 T cells in uninfected and HIV-1 bi-
ological clone-infected cultures was determined by FACScan
flow cytometry (Fig. 3). The percentage of CD4 T cells in the
HC4 clone-infected culture dramatically declined over 5 to 8
days postinfection. Between days 3 and 5 postinfection, CD4
T cells declined from 82 to 46% (lower right quadrant, Fig. 3c).
By day 7 postinfection, the percentage of CD4 T cells decreased
to 13% and by day 10 there was <3% in the culture. In con-
trast, by day 5 postinfection, there was —86% of CD4 T cells
in the GC6 8-4-infected culture (Fig. 3b), and -81% of CD4
T cells in the uninfected culture (not shown) or mock-infected
culture (Fig. 3a). The cells in the lower left quadrant represent
viable T cells that have downregulated their CD4 antigen ex-
pression due to viral infection. On day 7 postinfection, 56% of
T cells in the GC6 8-4-infected culture expressed CD4 antigen
and 31% of viable T cells had downregulated their expression
of CD4 antigen. Since CD4 antigen expression is not affected
in uninfected or mock-infected cells, —82% of either culture
were CD4 T cells. The total number of CD4 T cells remained
steady (67-80%) over the period of the experiment (10 days)
in uninfected cultures, in mock-infected cultures, or in cultures
infected with the GC6 8-4 clone (lower left and right quadrants;
Fig. 3a and b). In contrast, the total number of CD4 T cells in
HC4-infected culture was only —30% by day 7 postinfection,
and rapidly decreased to —15% by day 10.
Cytopathogenic patient HIV-1 decreases mitochondrial
viability in infected CD4 T cells
The results described above suggest that HC4 virus is cy-
topathogenic to CD4 T cells in the absence of syncytium for-
mation. Viral replication appeared not to be the major con-
tributing factor since GC6 8-4 virus with similar replication
levels was noncytopathogenic to CD4 T cells (Fig. 2a-c; Table
2). We have shown previously that mitochondrial viability
steadily decreases prior to cell death induced by cytopathogenic
laboratory isolates of HIV-1.8 To determine whether mito-
chondrial viability decreased in CD4 T cells infected with the
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FIG. 2. Viability of CD4 T cells infected with functional, biologically cloned patient HIV-1. CD4 T cells were enriched ac-
cording to the procedure outlined in Materials and Methods. CD4 T cells were infected with titered biological HIV-1 clones iso-
lated from asymptomatic (patient A) or symptomatic (patient D) individuals, or infected with a po/-defective NL4-3 strain of
virus derived from 8E5 cells (mock infection). After the initial exposure to the virus, the culture was carried out in the presence
of anti-CD4 monoclonal antibody to inhibit syncytium formation and secondary infections. Single cell death was determined us-
ing the trypan blue dye exclusion assay and percent viable cells was calculated. HIV-1 replication in infected CD4 T cell cul-
tures was measured by assaying cell-free culture supernatants for HIV-1 p24#a« protein, using an antigen capture ELISA, (a)
Percent viable cells in infected CD4 T cells, (b) Total number of viable cells in cultures of CD4 T cells mock infected or in-
fected with biological HIV-1 clones, (c) HIV-1 p24*a* protein from infected CD4 T cells. HC4, Cytopathogenic HIV-1 clone
from patient D; GC6 8-4, noncytopathogenic HIV-1 clone from patient A.
CP HC4 virus, infected and uninfected cells were stained with
rhodamine-123 dye and the histograms were statistically ana-
lyzed. The D/s(n) value between the histograms of uninfected
cells and HC4-infected cells dramatically increased over the pe-
riod of day 3 to day 7 postinfection. On day 3 postinfection it
was 1.19, which increased to 6.52 by day 5, and to 13.04 by
day 7 (Table 2). These data demonstrate that the rhodamine-
123 fluorescence of infected cells was greatly reduced and pro-
vide evidence that the number of functionally viable mito-
chondria was very low in comparison to uninfected cells. In
contrast, the levels of viable mitochondria in CD4 T cells in-
fected with the NCP HIV-1 clone GC6 8-4 were similar to the
levels of viable mitochondria in uninfected or mock-infected
CD4 T cells (Table 2). The D/s(n) value between the histograms
of uninfected cells and GC6 8-4-infected cells was 1.89 on day
3 postinfection, with minimal change to 2.02 on day 5 and to
2.28 on day 7 postinfection (Table 2).
DISCUSSION
In vivo infection with HIV-1 is typically characterized by
progressive clinical and immunological deterioration associated
with a decrease in CD4 T cells. The mechanism of CD4 T cell
depletion in vivo and its role in HIV-1 pathogenesis and de-
velopment of AIDS are not well understood. Earlier reports
have proposed syncytium formation and high viral burden as
potential mechanisms of in vivo CD4 T cell attrition.4,9,10 Two
studies indicate that CD4 T cell depletion is associated with
high levels of virus production.11,12 These reports suggest that
viral load/replication is primarily responsible for HIV-1 patho-
genesis. However, we have identified rare, vertically infected
individuals who have maintained normal CD4 T cell counts and
who have remained asymptomatic in spite of persistently high
peripheral blood viremia. One such individual described in this
report, patient A, has normal CD4 T cell counts (1231/mm3)
and has remained asymptomatic for the past 7 years despite
high viral load in vivo. The HIV-1 p24 antigen level in serum
from patient A as determined by immune complex dissociation
assay was 1773 pg/ml. Viral RNA copies in plasma were
280,000/ml. These individuals provide a unique opportunity to
study viral determinants of HIV-1-induced CD4 T cell de-
struction.
We have previously shown that (1) the syncytium-inducing
ability of patient HIV-1 isolates is not always correlated with
induction of CD4 T cell death; (2) HIV-1 isolates replicate in
MT-2 cells in the absence of syncytium formation; and (3) pro-
gressive immune deficiency occurs in vivo in patients who do
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not have SI viral isolates.27 In this article we have described a
cell culture system to study in vitro cytopathic effects of pri-
mary HIV-1 isolates that are independent of syncytium forma-
tion and secondary infection. We also observed that viral repli-
cation alone does not predict the single cell killing capacity of
primary HIV-1 isolates. HIV-1 isolates from an asymptomatic
individual with normal CD4 T cell numbers and a symptomatic
individual with CD4 T cell depletion replicated to equivalent
levels of p24 antigen in primary CD4 T cells. However, the iso-
late from the symptomatic individual induced cell death and the
isolate from the asymptomatic individual was noncytopatho-
genic. It is known that HTV-1 exists in the host as a group of
related viruses known as a quasispecies.28 This diversity allows
the virus a broad spectrum of genotypes that result in multiple
phenotypic properties. It follows then that a single viral isolate
may contain a number of variants that differ in their ability to
form syncytia, and that differ in cell tropism, replication kinet-
ics, as well as cytopathogenic potential. Interestingly, func-
tionally active biological clones isolated from the noncy-
topathogenic isolate did not induce cell death in our culture sys-
tem in spite of levels of viral replication equivalent to those
seen with biological clones of a cytopathogenic isolate that in-
duced cell death.
The mechanism(s) of HIV-1-induced cell death are not well
understood. Our hypothesis is that intracellular events after vi-
ral entry in combination with cellular/viral factors intricately
involved in the viral life cycle may play a major role in the cy-
topathic effects of HIV-1. We have previously shown that cy-
topathogenic HIV-1 laboratory isolates decrease mitochondrial
viability in infected CD4 T cells and cause cell death.8 We have
also demonstrated that concomitant to the decrease in mito-
chondrial viability, HIV-1 RNA localized within mitochondria.8
The decrease in mitochondrial viability preceded cell death in
cells infected with cytopathogenic HIV-1, suggesting that the
loss of mitochondrial viability was the cause and not the effect
of cell death.8 The levels of viable mitochondria in cells in-
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FIG. 3. Determination of percent CD4 and CD8 T cells in CD4 T cell-enriched cultures infected with cytopathogenic or non-
cytopathogenic HIV-1 biological clones. CD4 T cells were enriched and infected with a cytopathogenic HC4 biological clone, or
a noncytopathogenic GC6 8-4 biological clone, as described in the caption to Fig. 2. The percentage of CD4+ and CD8+ T cells
in the infected cultures on days 3, 5, 7, and 10 postinfection was determined by FACScan flow cytometer, according to the pro-
cedures described in Materials and Methods, and is given in the lower quadrants of the panels, (a) Mock-infected cultures; (b)
noncytopathogenic, GC6 8-4 clone-infected cultures; (c) cytopathogenic, HC4 clone-infected cultures.
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fected with noncytopathogenic HIV-1 biological clone GC6 8-
4 were similar to the levels of viable mitochondria in uninfected
cells, while in the cells infected with CP HIV-1 biological clone
HC4 there was a dramatic decline in mitochondrial viability,
suggesting a possible role for mitochondria in HIV-1 cy-
topathogenicity. Wbile the results are suggestive of a causal
link between mitochondrial viability and cell death more de-
finitive experiments are necessary. The association of HIV-1-
induced cell death and mitochondrial dysfunction and mito-
chondrial disintegration is not without precedence. Macho et al.
reported their findings on mitochondrial dysfunction in circu-
lating T lymphocytes of individuals infected with HIV-1.29
They observed a correlation between increased disruption of
mitochondrial membrane potential in T cells and disease pro-
gression and suggested a potential role for mitochondria in in
vivo CD4 T cell loss. These investigators, however, did not de-
termine mitochondrial dysfunction specifically in HIV-1-in-
fected CD4 T cells. HIV-1 is not the only lentivirus associated
with mitochondrial dysfunction. In vitro infection of cell lines
with feline immunodeficiency virus (FIV) also resulted in a re-
duction in mitochondrial transmembrane potential prior to cell
death.30 Taken together, the data support a potential role for
mitochondria in virus-induced cell death.
Although the mechanism(s) of HIV-1-induced loss of mito-
chondrial viability is unclear and the potential role of cellu-
lar/viral factors in this process has not been identified, patient-
derived biological HIV-1 clones and the in vitro culture system
described in this article will be useful in future studies to de-
termine the role of mitochondria or other cellular/viral factors
in HIV-1 pathogenesis. In addition, molecular and functional
analyses of the biological clones to determine the gene(s) re-
sponsible for cytopathogenicity will assist in the development
of new therapeutic modalities.
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